Nephrectomy clinical trials

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

This study looks at a new drug, nivolumab, for kidney cancer that hasn't spread. It compares surgery alone to surgery plus nivolumab to see if the drug can stop the cancer from coming back. It's a phase 3 trial, meaning it's in its later stages of testing.